Curcumin protects against thioacetamide-induced hepatic fibrosis by attenuating the inflammatory response and inducing apoptosis of damaged hepatocytes.

[1]  Hartmut Jaeschke,et al.  Reactive oxygen and mechanisms of inflammatory liver injury: Present concepts , 2011, Journal of gastroenterology and hepatology.

[2]  Xuetao Cao,et al.  Apoptotic cells attenuate fulminant hepatitis by priming Kupffer cells to produce interleukin‐10 through membrane‐bound TGF‐β , 2011, Hepatology.

[3]  D. Meek.  Tumour suppression by p53: a role for the DNA damage response? , 2009, Nature Reviews Cancer.

[4]  Jianguo Lin,et al.  Curcumin attenuates the effects of insulin on stimulating hepatic stellate cell activation by interrupting insulin signaling and attenuating oxidative stress , 2009, Laboratory Investigation.

[5]  D. Lee,et al.  Reactive oxygen species up‐regulate p53 and Puma; a possible mechanism for apoptosis during combined treatment with TRAIL and wogonin , 2009, British journal of pharmacology.

[6]  C. Chi,et al.  Study on antifibrotic effects of curcumin in rat hepatic stellate cells , 2009, Phytotherapy research : PTR.

[7]  G. Schultz,et al.  Interactions between extracellular matrix and growth factors in wound healing , 2009, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[8]  Y. Rojanasakul,et al.  Curcumin Sensitizes Lung Cancer Cells to Cisplatin-Induced Apoptosis Through Superoxide Anion-Mediated Bcl-2 Degradation , 2009, Cancer investigation.

[9]  S. Fukushima,et al.  Role of CYP2E1 in thioacetamide-induced mouse hepatotoxicity. , 2008, Toxicology and applied pharmacology.

[10]  Jianguo Lin,et al.  Activation of peroxisome proliferator-activated receptor-γ by curcumin blocks the signaling pathways for PDGF and EGF in hepatic stellate cells , 2008, Laboratory Investigation.

[11]  Rebecca C Taylor,et al.  Apoptosis: controlled demolition at the cellular level , 2008, Nature Reviews Molecular Cell Biology.

[12]  Y. Kong,et al.  Curcumin induces apoptosis through mitochondrial hyperpolarization and mtDNA damage in human hepatoma G2 cells. , 2007, Free radical biology & medicine.

[13]  P. Muriel,et al.  Curcumin protects against acute liver damage in the rat by inhibiting NF-kappaB, proinflammatory cytokines production and oxidative stress. , 2007, Biochimica et biophysica acta.

[14]  Karen H. Vousden,et al.  p53 in health and disease , 2007, Nature Reviews Molecular Cell Biology.

[15]  K. Shankar,et al.  Role of CYP2E1 and saturation kinetics in the bioactivation of thioacetamide: Effects of diet restriction and phenobarbital. , 2007, Toxicology and applied pharmacology.

[16]  S. Shankar,et al.  Curcumin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells: molecular mechanisms of apoptosis, migration and angiogenesis , 2007, Journal of molecular signaling.

[17]  G. Wahl,et al.  Regulating the p53 pathway: in vitro hypotheses, in vivo veritas , 2006, Nature Reviews Cancer.

[18]  Wei Gu,et al.  p53 ubiquitination: Mdm2 and beyond. , 2006, Molecular cell.

[19]  C. Sempoux,et al.  Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice. , 2004, Journal of hepatology.

[20]  L. Weber,et al.  Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological Model , 2003, Critical reviews in toxicology.

[21]  J. Rhim,et al.  Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines. , 2002, International journal of oncology.

[22]  S. Lowe,et al.  Dissecting p53 tumor suppressor functions in vivo. , 2002, Cancer cell.

[23]  D. Bissell.  Chronic liver injury, TGF-β, and cancer , 2001, Experimental & Molecular Medicine.

[24]  A. Álvarez,et al.  Influence of aminoguanidine on parameters of liver injury and regeneration induced in rats by a necrogenic dose of thioacetamide , 1998, British journal of pharmacology.

[25]  D. Discher,et al.  Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V. , 1996, Blood.

[26]  D. Green,et al.  Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl , 1995, The Journal of experimental medicine.

[27]  D. Nicholson,et al.  Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B , 1995, Nature.

[28]  Muneesh Tewari,et al.  Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase , 1995, Cell.

[29]  K. Kohn,et al.  Induction of a common pathway of apoptosis by staurosporine. , 1994, Experimental cell research.

[30]  G. Merlino,et al.  Establishment and characterization of differentiated, nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor alpha. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M. Bogdanffy,et al.  Evaluation of proliferating cell nuclear antigen (PCNA) as an endogenous marker of cell proliferation in rat liver: a dual-stain comparison with 5-bromo-2'-deoxyuridine. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[32]  M. Fujikawa,et al.  Different patterns of leakage of cytosolic and mitochondrial enzymes. , 1989, Clinica chimica acta; international journal of clinical chemistry.

[33]  S. Friedman,et al.  Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[34]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[35]  R. A. Neal,et al.  Thioacetamide-induced hepatic necrosis. I. Involvement of the mixed-function oxidase enzyme system. , 1977, The Journal of pharmacology and experimental therapeutics.

[36]  E. Smuckler,et al.  Nonhepatic Thioacetamide Injury: II. The Morphologic Features of Proximal Renal Tubular Injury , 1974 .

[37]  R. Bataller,et al.  Amendment history : Corrigendum ( April 2005 ) Liver fibrosis Ramón Bataller , 2018 .

[38]  D. Bissell.  Chronic liver injury, TGF-beta, and cancer. , 2001, Experimental & molecular medicine.

[39]  K O'Rourke,et al.  Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. , 1995, Cell.

[40]  D. Bissell,et al.  The role of extracellular matrix in normal liver. , 1988, Scandinavian journal of gastroenterology. Supplement.